March 20, 2018

Broadspire Enhances CAMP Program

Atlanta, GA – Broadspire recently announced that it has enhanced its innovative Comprehensive Assessment and Management of Pain (CAMP) Program to address the needs of injured and disabled workers and their employers by adding an opioid tapering component this month as well as the first opioid fill program in September 2014. First introduced at this year’s national RIMS Conference, the CAMP program uses evidence‐based medicine along with an integrated systemic approach to identify and address the needs of individuals in pain. Broadspire is a leading global third‐party administrator of workers compensation claims, liability claims and medical management services.

“CAMP is built on evidence‐based medical research with a documented a set of proven methods and tools that have been structured into a comprehensive, systematic, integrated and cost‐effective approach to yield optimal outcomes for employees and employers,” said Dr. Jacob Lazarovic, MD, FAAFP, senior vice president and chief medical officer, Broadspire.  “The overarching philosophy of this program is that pain is a biopsychosocial condition, and that failure to adequately address all these components will often result in unfavorable results.”

There is broad recognition in the medical management industry that chronic pain is one of the central issues in workers compensation that must be managed in order to successfully contain medical and indemnity expenses, and to maximize the comfort, functionality, quality of life, and return‐to‐work capacity of injured workers.

The massive scope of managing pain in patients is based on the size of the affected population and estimated treatment costs, including:

  • Studies indicate that the median prevalence of chronic pain in our population is 15%.
  • The economic burden of pain, combining medical costs and lost productivity, is estimated at $600 billion annually.
  • Prescription costs may constitute up to 19% of total medical expenses, and opioids represent 30% of these costs.
  • The “opioid epidemic” has resulted in up to a nine‐fold increase in morbidity and mortality, with little evidence that opioid pain medications may confer long‐term benefit despite the escalation of opioid dosages over the years.
  • Physician dispensing of medications has emerged as a trend which further exacerbates the problem, creating unfavorable incentives for prolonged analgesic use and disability.

The objectives of the CAMP Program are:

  • Early identification of high‐risk individuals, which incorporate a new “first opioid fill” component. Within two weeks of initiation of opioids, contact is made with the treating physician and patient, and systematic education and intervention are triggered.
  • Timely evaluation and intervention to prevent and/or impact chronicity.
  • Effective use of internal and external resources, ensuring coordinated selection, application and management of the appropriate expertise.
  • Establishment and measurement of program outcomes using metrics related to clinical quality, medical costs, and return‐to‐work.

CAMP components include: narcotic intervention; specimen drug monitoring; cognitive behavioral therapy; opioid tapering and addiction therapy; functional restoration / interdisciplinary pain management; and pharmacogenomic testing. The program integrates seamlessly with all of Broadspire’s medical management resources and specialty partners.

Source: Broadspire

  • RSS
  • Twitter
  • LinkedIn